Krebs Biochemicals and Industries Limited (KREBSBIO) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE268B01013
Key metrics
- Market Cap
- ₹127 Cr
- P/E Ratio
- —
- EPS
- -6.21
- Book Value
- -75.49
- P/B Ratio
- —
- ROE
- 10.4%
- ROCE
- -19.13%
- Debt / Equity
- -1.38
- Net Margin
- -71.35%
- Revenue Growth
- -45.21%
- Profit Growth
- 37.14%
- Dividend Yield
- —
- 52W High
- ₹82.49
- 52W Low
- ₹38.33
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Krebs Biochemicals and Industries Limited
Krebs Biochemicals & Industries Limited engages in the manufacture and sale of active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry. Its products include androstenedione, lovastatin, and simvastatin, which are used for anti-cholesterol and steroid intermediate applications. The company also develops various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. Krebs Biochemicals & Industries Limited was incorporated in 1991 and is based in Visakhapatnam, India.
- Headquarters
- Visakhapatnam, India
- Promoter Holding
- 81.12%
The full Krebs Biochemicals and Industries Limited analysis
Create a free account to open the complete KREBSBIO deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.